1. A phase II, multi-center randomized, open label study to compare the antiretroviral activity and tolerability of efavirenz (EFV)+indinavir (IDV), versus EFV+zidovudine (ZDV)+lamivudine (3TC), versus IDV +3TC at >36weeks (DMP 266–006);Morales-Ramirez,1998
2. Efavirenz;Adkins;Drugs,1998
3. Efavirenz in the management of HIV infection;Gazzard;Int J Clin Pract,1999
4. Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial;Haas;J Infect Dis,2001
5. Hepatic but not intestinal CYP3A4 displays dose-dependent induction by efavirenz in humans;Mouly;Clin Pharmacol Ther,2002